EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ganglioside GM3 in the Tumor Microenvironment: Mechanisms of Signaling Regulation and Strategies for Angiogenesis Inhibition

Min Zeng, Hongda Zhuang iD, Siyuan Zhao, Roger Chammas iD, Yong Chen iD

Biomolecules · 19.03.2026 · 16 (3) · 464

DOI: 10.3390/biom16030464 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 19.03.2026. Verfasst von Min Zeng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Advanced Study, Nanchang University, Nanchang 330031, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, G(M3) Ganglioside, Neovascularization, Pathologic, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ganglioside GM3, a fundamental glycosphingolipid on the mammalian cell surface, is a key regulator of transmembrane signaling and cellular recognition. In oncology, GM3 acts as a tumor suppressor by modulating the activity of various receptor tyrosine kinases (RTKs) and their downstream pathways. Recent studies highlight its function in the tumor microenvironment (TME), specifically its ability to impede pathological angiogenesis. This review summarizes the molecular mechanisms by which GM3 interferes with pro-angiogenic signaling, such as the VEGF/VEGFR axis, and discusses how this inhibition can be used for therapy. We explore the clinical potential of GM3-based strategies, including monoclonal antibodies and cancer vaccines, discussing the potential of targeting GM3 to reshape the TME and suppress tumor-associated vascularization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentG(M3) GangliosideNeovascularization, PathologicNeoplasmsAngiogenesis InhibitorsHumansSignal TransductionAnimalsVascular Endothelial Growth Factor A

Stichwörter der Autor:innen

HIF-1αVEGF signalingganglioside GM3targeted therapytumor angiogenesistumor microenvironment

Substanzen

G(M3) GangliosideVascular Endothelial Growth Factor AAngiogenesis Inhibitors

Autor:innen und Institutionen

  • Institute for Advanced Study, Nanchang University, Nanchang 330031, China.
  • The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Pharmacy, Nanchang University, Nanchang 330031, China.
  • Department of Pharmacology, Physiology and Neuroscience, New Jersey Medical School, Rutgers University, Newark, NJ 07103, USA.
  • Center for Translational Research in Oncology, University of São Paulo, São Paulo 01246-000, Brazil.

ORCID-Profile: Hongda Zhuang, Roger Chammas, Yong Chen

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zeng, M., Zhuang, H., Zhao, S., Chammas, R., & Chen, Y. (2026). Ganglioside GM3 in the Tumor Microenvironment: Mechanisms of Signaling Regulation and Strategies for Angiogenesis Inhibition. Biomolecules, 16(3), 464. https://doi.org/10.3390/biom16030464

Vancouver

Zeng M, Zhuang H, Zhao S, Chammas R, Chen Y. Ganglioside GM3 in the Tumor Microenvironment: Mechanisms of Signaling Regulation and Strategies for Angiogenesis Inhibition. Biomolecules. 2026;16(3):464. doi:10.3390/biom16030464

BibTeX
@article{Zeng2026,
  author = {Zeng, Min and Zhuang, Hongda and Zhao, Siyuan and Chammas, Roger and Chen, Yong},
  title = {Ganglioside GM3 in the Tumor Microenvironment: Mechanisms of Signaling Regulation and Strategies for Angiogenesis Inhibition},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {464},
  doi = {10.3390/biom16030464}
}
Kostenlos starten →